Flamazine · DIN 00323098 · 1% · Cr
General benefit; Health Canada lists this DIN as Cancelled post market since 2026-01-12 — choose a marketed DIN from the same-category list.Discontinued January 12, 2026 · checked November 20, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2026-01-12 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2026-01-12 — choose a marketed DIN from the same-category list.
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
Flamazine · DIN 00323098
Manufacturer: Smith & Nephew Inc.; listing date 1996-10-01
Health Canada: Cancelled post market since 2026-01-12 · brand FLAMAZINE · ATC D06BA01 SILVER SULFADIAZINE · form Cream · route Topical · ingredients SILVER SULFADIAZINE 1 % · company Smith & nephew inc · schedule Prescription
Flamazine: Formulary list price $0.13 per unit (the source does not state the unit; exact figure $0.1320). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00323098)
Source record
DIN 00323098: Flamazine
Raw flags: sec3=Y
Item: 840416023; group id 833; item number 2026; lccId None; manufacturer id SNE
Source form: Cr; strength: 1%
Recorded listing: General benefit
Source prices (unrounded): $0.1320; ministry $0.1320
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00323098
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=2146
Therapeutic Notes (formulary)
The listing of Flamazine 1% Cr (DIN 00323098) is for the 500g jar package format.
Shortage status: not checked (no credentials)
Health Canada lists this DIN as Cancelled post market since January 12, 2026 — choose a marketed DIN from the same-category list.